Sale!

CETROLIX

CETRORELIX ACETATE INJECTION

2-8* C
MRP : MRP 1,482.42
Price : 800.00
You Save : 682.42 (46.03%)

1 vial(s)

Buy Now
SKU: 360 Category: Tags: , Brand:

Cetrolix 0.25mg injection is a hormonal agent, specifically a gonadotropin-releasing hormone (GnRH) antagonist, containing the active ingredient Cetrorelix. Its primary use is in the treatment of female infertility, where it plays a crucial role in synchronizing the development of multiple ovarian follicles, thereby ensuring their optimal retrieval during in-vitro fertilization (IVF) procedures.

However, there are important contraindications and precautions to observe with Cetrolix 0.25mg injection. It is contraindicated in individuals with a known hypersensitivity or allergy to Cetrorelix or any of its components. Patients with pre-existing kidney or liver problems should inform their physician, as these conditions may necessitate special monitoring or dose adjustments. Cetrolix 0.25mg injection is frequently used in conjunction with other medications to stimulate the ovaries as part of comprehensive fertility treatment. A significant risk associated with its use, especially when combined with ovarian stimulants, is the increased chance of developing Ovarian Hyperstimulation Syndrome (OHSS). OHSS is a condition characterized by enlarged ovaries and the potential formation of cysts. It is vital to contact your physician immediately if you experience symptoms such as severe pelvic pain, bloating, nausea, vomiting, or sudden weight gain, as these could be indicative of OHSS.

Furthermore, you should report to your physician without delay if you experience sudden, potentially life-threatening allergic reactions, including difficulty breathing or wheezing, swelling, rash, itching, fever, and chills. This drug is not intended for use in children. It is essential to inform your physician about all other medications you are currently using, have recently used, or may use, as they can interact with Cetrolix 0.25mg injection. The use of this drug in pregnant and breastfeeding women is not recommended; therefore, consult your doctor for further advice before initiating treatment if you fall into these categories.